Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation.

Möhlmann JE, van Luin M, Mascini EM, van Leeuwen HJ, de Maat MR.

Eur J Clin Pharmacol. 2019 Jun;75(6):831-836. doi: 10.1007/s00228-019-02644-x. Epub 2019 Feb 18.

PMID:
30778624
2.

Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study.

Platteel TN, Leverstein-van Hall MA, Cohen Stuart JW, Thijsen SF, Mascini EM, van Hees BC, Scharringa J, Fluit AC, Bonten MJ.

Clin Microbiol Infect. 2015 Feb;21(2):141-6. doi: 10.1016/j.cmi.2014.09.014. Epub 2014 Oct 29.

3.

A rapid and high-throughput screening approach for methicillin-resistant Staphylococcus aureus based on the combination of two different real-time PCR assays.

Nijhuis RH, van Maarseveen NM, van Hannen EJ, van Zwet AA, Mascini EM.

J Clin Microbiol. 2014 Aug;52(8):2861-7. doi: 10.1128/JCM.00808-14. Epub 2014 May 28.

4.

New screening method to detect carriage of carbapenemase-producing Enterobacteriaceae in patients within 24 hours.

Hanemaaijer NM, Nijhuis RH, Slotboom BJ, Mascini EM, van Zwet AA.

J Hosp Infect. 2014 May;87(1):47-9. doi: 10.1016/j.jhin.2014.03.003. Epub 2014 Mar 26.

PMID:
24746789
5.

Foreign adopted children are a source of methicillin-resistant Staphylococcus aureus transmission to countries with low prevalence.

Hagleitner MM, Mascini EM, van Berkel S, Bosman J, Mulder JC, van Setten PA.

Pediatr Infect Dis J. 2012 Jun;31(6):655-8. doi: 10.1097/INF.0b013e3182535dc6.

PMID:
22481429
6.

Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study.

de Smet AM, Kluytmans JA, Blok HE, Mascini EM, Benus RF, Bernards AT, Kuijper EJ, Leverstein-van Hall MA, Jansz AR, de Jongh BM, van Asselt GJ, Frenay IH, Thijsen SF, Conijn SN, Kaan JA, Arends JP, Sturm PD, Bootsma MC, Bonten MJ.

Lancet Infect Dis. 2011 May;11(5):372-80. doi: 10.1016/S1473-3099(11)70035-4. Epub 2011 Mar 21.

PMID:
21420908
7.

Ecological effects of selective decontamination on resistant gram-negative bacterial colonization.

Oostdijk EA, de Smet AM, Blok HE, Thieme Groen ES, van Asselt GJ, Benus RF, Bernards SA, Frénay IH, Jansz AR, de Jongh BM, Kaan JA, Leverstein-van Hall MA, Mascini EM, Pauw W, Sturm PD, Thijsen SF, Kluytmans JA, Bonten MJ.

Am J Respir Crit Care Med. 2010 Mar 1;181(5):452-7. doi: 10.1164/rccm.200908-1210OC. Epub 2009 Dec 3.

PMID:
19965807
8.

Decontamination of the digestive tract and oropharynx in ICU patients.

de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harinck HI, Voss A, Uijtendaal EV, Blok HE, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ.

N Engl J Med. 2009 Jan 1;360(1):20-31. doi: 10.1056/NEJMoa0800394.

9.

[A midwife involved in patients with puerperal fever in three different hospitals].

Kaan JA, van Dijk Y, Mascini EM, van Kessel RP, Schellekens JF.

Ned Tijdschr Geneeskd. 2008 Oct 11;152(41):2245-8. Dutch.

PMID:
19009813
10.

[Invasive Lancefield group A streptococcal infections in the Netherlands].

Vlaminckx BJ, Mascini EM, Schellekens JF.

Ned Tijdschr Geneeskd. 2007 Jul 28;151(30):1669-73. Review. Dutch.

PMID:
17725254
11.

Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001.

van den Broek PJ, Arends J, Bernards AT, De Brauwer E, Mascini EM, van der Reijden TJ, Spanjaard L, Thewessen EA, van der Zee A, van Zeijl JH, Dijkshoorn L.

Clin Microbiol Infect. 2006 Sep;12(9):837-43.

12.

Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium.

Mascini EM, Troelstra A, Beitsma M, Blok HE, Jalink KP, Hopmans TE, Fluit AC, Hene RJ, Willems RJ, Verhoef J, Bonten MJ.

Clin Infect Dis. 2006 Mar 15;42(6):739-46. Epub 2006 Feb 10.

PMID:
16477546
13.

Extensive hospital-wide spread of a multidrug-resistant enterobacter cloacae clone, with late detection due to a variable antibiogram and frequent patient transfer.

Leverstein-van Hall MA, Blok HE, Paauw A, Fluit AC, Troelstra A, Mascini EM, Bonten MJ, Verhoef J.

J Clin Microbiol. 2006 Feb;44(2):518-24.

14.

Methicillin-resistant Staphylococcus aureus carriage among patients after hospital discharge.

Vriens MR, Blok HE, Gigengack-Baars AC, Mascini EM, van der Werken C, Verhoef J, Troelstra A.

Infect Control Hosp Epidemiol. 2005 Jul;26(7):629-33.

PMID:
16092743
15.

Vancomycin-resistant enterococci: consequences for therapy and infection control.

Mascini EM, Bonten MJ.

Clin Microbiol Infect. 2005 Jul;11 Suppl 4:43-56. Review.

16.

Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003.

Vlaminckx BJ, van Pelt W, Schouls LM, van Silfhout A, Mascini EM, Elzenaar CP, Fernandes T, Bosman A, Schellekens JF.

Clin Microbiol Infect. 2005 Mar;11(3):226-31.

17.

[Vancomycin resistant enterococci in the Netherlands].

Leavis HL, Willems RJ, Mascini EM, Vandenbroucke-Grauls CM, Bonten MJ.

Ned Tijdschr Geneeskd. 2004 May 1;148(18):878-82. Review. Dutch.

PMID:
15152389
18.

Resistance of Staphylococcus aureus to fusidic acid.

Peeters KA, Mascini EM, Sanders CJ.

Int J Dermatol. 2004 Mar;43(3):235-6. No abstract available.

PMID:
15009402
19.

Molecular epidemiology of coagulase-negative staphylococci causing sepsis in a neonatal intensive care unit over an 11-year period.

Krediet TG, Mascini EM, van Rooij E, Vlooswijk J, Paauw A, Gerards LJ, Fleer A.

J Clin Microbiol. 2004 Mar;42(3):992-5.

20.

[A pseudo-epidemic of puerperal sepsis].

Dietz V, Derks JB, Mascini EM, Bruinse HW.

Ned Tijdschr Geneeskd. 2003 Dec 20;147(51):2505-8. Dutch.

PMID:
14735848
21.

Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.

Mascini EM, Jalink KP, Kamp-Hopmans TE, Blok HE, Verhoef J, Bonten MJ, Troelstra A.

J Clin Microbiol. 2003 Dec;41(12):5377-83.

22.

Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants.

Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC, Novak R, Verhoef J, Schmitz FJ.

J Clin Microbiol. 2003 Nov;41(11):4941-9.

23.

Epidemic and nonepidemic multidrug-resistant Enterococcus faecium.

Leavis HL, Willems RJ, Top J, Spalburg E, Mascini EM, Fluit AC, Hoepelman A, de Neeling AJ, Bonten MJ.

Emerg Infect Dis. 2003 Sep;9(9):1108-15.

24.

Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital.

Blok HE, Troelstra A, Kamp-Hopmans TE, Gigengack-Baars AC, Vandenbroucke-Grauls CM, Weersink AJ, Verhoef J, Mascini EM.

Infect Control Hosp Epidemiol. 2003 Sep;24(9):679-85.

PMID:
14510251
25.

Surveillance for hospital-acquired infections on surgical wards in a Dutch university hospital.

Kamp-Hopmans TE, Blok HE, Troelstra A, Gigengack-Baars AC, Weersink AJ, Vandenbroucke-Grauls CM, Verhoef J, Mascini EM.

Infect Control Hosp Epidemiol. 2003 Aug;24(8):584-90.

PMID:
12940579
26.

Dry cleaning or wet mopping: comparison of bacterial colony counts in the hospital environment.

Ballemans CA, Blok HE, Swennenhuis J, Troelstra A, Mascini EM.

J Hosp Infect. 2003 Feb;53(2):150-2. No abstract available.

PMID:
12586578
27.

The hidden faces of the epidemiology of antibiotic resistance.

Bonten MJ, Mascini EM.

Intensive Care Med. 2003 Jan;29(1):1-2. Epub 2002 Nov 20. No abstract available.

PMID:
12528013
28.

[Epidemic of methicillin-resistant Staphylococcus aureus due to the transfer of 2 Dutch burn patients from a hospital outside of the Netherlands; who suffers the consequences?].

Troelstra A, Kamp-Hopmans TE, Wessels FJ, Bilkert-Mooiman MA, Verhoef J, Mascini EM.

Ned Tijdschr Geneeskd. 2002 Nov 16;146(46):2204-7. Dutch.

PMID:
12467166
29.

[Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].

Peeters KA, Mascini EM, Blok HE, Sanders CJ.

Ned Tijdschr Geneeskd. 2002 Nov 2;146(44):2100-1. Dutch.

PMID:
12448968
30.

Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit.

van Dessel H, Kamp-Hopmans TE, Fluit AC, Brisse S, de Smet AM, Dijkshoorn L, Troelstra A, Verhoef J, Mascini EM.

J Hosp Infect. 2002 Jun;51(2):89-95.

PMID:
12090795
31.

Genotyping of clinical methicillin-susceptible Staphylococcus aureus isolates in a Dutch teaching hospital.

Van Dijk Y, Wielders CL, Fluit AC, Paauw A, Diepersloot RJ, Mascini EM.

J Clin Microbiol. 2002 Feb;40(2):663-5.

32.

Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.

Mascini EM, Jansze M, Schouls LM, Verhoef J, Van Dijk H.

Int J Antimicrob Agents. 2001 Oct;18(4):395-8.

PMID:
11691576
33.

Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals.

Willems RJ, Homan W, Top J, van Santen-Verheuvel M, Tribe D, Manzioros X, Gaillard C, Vandenbroucke-Grauls CM, Mascini EM, van Kregten E, van Embden JD, Bonten MJ.

Lancet. 2001 Mar 17;357(9259):853-5.

PMID:
11265956
34.

[Epidemiologic increase of various genotypes of vancomycin-resistant Enterococcus faecium in a university hospital].

Mascini EM, Gigengack-Baars AC, Hené RJ, Kamp-Hopmans TE, Weersink AJ, Bonten MJ.

Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2572-6. Dutch.

PMID:
11191796
35.

[What is to be done with vancomycin-resistant enterococcal infections?].

Bonten MJ, Mascini EM, Willems R, Timmer GJ, Gaillard CA, Vandenbroucke-Grauls CM.

Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2545-9. Review. Dutch.

PMID:
11191789
36.

Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.

Mascini EM, Jansze M, Schellekens JF, Musser JM, Faber JA, Verhoef-Verhage LA, Schouls L, van Leeuwen WJ, Verhoef J, van Dijk H.

J Infect Dis. 2000 Feb;181(2):631-8.

PMID:
10669348
37.

Relative avidities of human immunoglobulin G antibodies for streptococcal pyrogenic exotoxins A and B.

Mascini EM, Jansze M, Verhoef J, van Dijk H.

Clin Diagn Lab Immunol. 1999 Nov;6(6):977-80.

38.
39.

Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies.

Mascini EM, Hazenberg MM, van Dalen A, Verhoef-Verhage LA, van Leeuwen NJ, Verhoef J, van Dijk H.

Adv Exp Med Biol. 1997;418:921-2. No abstract available.

PMID:
9331799
40.

A new procedure for the purification of streptococcal pyrogenic exotoxin A from Streptococcus pyogenes supernatant.

Mascini EM, Hazenberg MA, Verhage LA, Holm SE, Verhoef J, van Dijk H.

Clin Diagn Lab Immunol. 1996 Nov;3(6):779-81.

41.

Phosphorylation of pyruvate kinase type K is restricted to the dimeric form.

Weernink PA, Rijksen G, Mascini EM, Staal GE.

Biochim Biophys Acta. 1992 May 22;1121(1-2):61-8.

PMID:
1599952

Supplemental Content

Loading ...
Support Center